Comments

Axsome Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Axsome Therapeutics (AXSM) operate in?

Axsome Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

AXSMNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$132.98

5.444.26%

Axsome Therapeutics (AXSM) Forecast

News Earnings Axsome Therapeutics (AXSM) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Axsome Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:AXSM | Benzinga

Explore Axsome Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for AXSM.

Open	-
Close	-
Volume / Avg.	3.64K / 922.63K
Day Range	- - -
52 Wk Range	64.11 - 139.13
Market Cap	$6.48B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	65
Short Interest	-
Days to Cover	4.55

Recent News

Axsome Says Symbravo Hits Primary Goal In Late-Stage Migraine Trial In Patients Experiencing Inadequate Response To Commonly Used Drugs

Axsome's Symbravo outperformed oral CGRP inhibitors in a Phase 3 trial, improving migraine pain relief, symptom control, and return to daily activities.

Vandana Singh

US, Russia Begin Ukrainian Peace Talks, Intel Shares Surge: What's Driving Markets Tuesday?

Major U.S. indices are little-changed in Tuesday's midday trading as investors monitor recent geopolitical developments and anticipate the release of the latest FOMC minutes on Wednesday.

Erica Kollmann

Axsome's AXS-05 In Alzheimer's Agitation Could Be Billion Dollar Opportunity, Says Analyst

Axsome Therapeutics reports strong Q4 2024 revenues, driven by increased sales of Auvelity and Sunosi. Anticipated milestones and FDA approval for Symbravo make AXSM a top pick for 2025.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	3.64K / 922.63K
Day Range	- - -
52 Wk Range	64.11 - 139.13
Market Cap	$6.48B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	65
Short Interest	-
Days to Cover	4.55

About Axsome Therapeutics Inc

Sector

Health Care

Industry

Pharmaceuticals

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Axsome Therapeutics (AXSM) stock?

You can purchase shares of Axsome Therapeutics (NASDAQ:AXSM) through any online brokerage.

View our list of the best stock brokerages

Who are Axsome Therapeutics (AXSM) competitors?

There are no as such competitors for Axsome Therapeutics.

What is the forecast, or price target, for Axsome Therapeutics (AXSM) stock?

Axsome Therapeutics has a consensus price target of $160.24.

What is the current price for Axsome Therapeutics (AXSM)?

The stock price for Axsome Therapeutics (NASDAQ: AXSM) is $132.9775 last updated March 3, 2025 at 8:10 AM EST.

Does Axsome Therapeutics (AXSM) pay a dividend?

There are no upcoming dividends for Axsome Therapeutics.

When is Axsome Therapeutics (NASDAQ:AXSM) reporting earnings?

Axsome Therapeutics’s Q1 earnings are confirmed for Monday, May 5, 2025.

Is Axsome Therapeutics (AXSM) going to split?

There is no upcoming split for Axsome Therapeutics.

What sector and industry does Axsome Therapeutics (AXSM) operate in?

Axsome Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.